Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind the erectile dysfunction gel Eroxon, ...

Zahid Iqbal told Liverpool Council he had "no idea" what was going on right under his nose ...

NEW SIZE ©Adobe Stock Images. Futura Medical (LSE:FUM) has overhauled its U.S. commercial strategy for Eroxon by ending its ...

Does male menopause aka ‘manopause’ really exist? Doctors explain what ‘manopause’ actually is, its symptoms, causes, ...

Multiple experts who reviewed the donation say the payment could qualify as a conflict because it has the potential to ...

The US government wants testosterone replacement therapy labels updated to reflect newer research on heart health and prostate cancer, but doctors stress that treatment should still be reserved for ...

Estrogen patches are in short supply as demand for menopause treatments skyrockets, and it could take at least a year for ...

The discourse surrounding England's upcoming battle with Mexico has given rise to some, well, interesting theories.

The surge in demand for testosterone therapy has opened up a lucrative market for clinics and wellness providers, but it has also raised concerns that some Kenyan men are exposing themselves to ...

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has ended its US partnership with consumer health giant Haleon PLC (LSE:HLN, ...

It's all over the internet, health podcasts, and even the New York Times: Half of all men over 40 “will suffer from erectile dysfunction at some point.” And indeed, every week, individuals and couples ...

Almost a dozen sexual enhancement supplements have triggered a safety alert from the medical regulator after they were found ...